{"product_id":"truqap-capivasertib-tab-200mg-c64","title":"Truqap (Capivasertib) Tab 200mg C64","description":"\u003ch2\u003eCategory\u003c\/h2\u003e\n\u003cp\u003ePrescription medicine\u003c\/p\u003e\n\n\u003ch2\u003eLine\u003c\/h2\u003e\n\u003cp\u003eOncologicals\u003c\/p\u003e\n\n\u003ch2\u003eBrand\u003c\/h2\u003e\n\u003cp\u003eTruqap\u003c\/p\u003e\n\n\u003ch2\u003eMolecule\u003c\/h2\u003e\n\u003cp\u003eCapivasertib\u003c\/p\u003e\n\n\u003ch2\u003ePresentation\u003c\/h2\u003e\n\u003cp\u003e200 mg Tablets\u003c\/p\u003e\n\n\u003ch2\u003eLaboratory\u003c\/h2\u003e\n\u003cp\u003eAstrazeneca\u003c\/p\u003e\n\n\u003ch2\u003eIndications\u003c\/h2\u003e\n\u003cp\u003eTruqap (Capivasertib) is indicated for the treatment of adult patients with metastatic breast cancer who have PIK3CA gene mutations and have progressed on previous therapies. This medication can be used in combination with other oncological treatments to improve therapeutic response and prolong survival in patients with this condition. It is important that the use of Truqap is carried out under the supervision of an oncology specialist, who will assess the need for its use based on the patient's clinical status and medical history.\u003c\/p\u003e\n\n\u003ch2\u003eComposition\u003c\/h2\u003e\n\u003cp\u003eEach Truqap tablet contains 200 mg of Capivasertib as the active ingredient. Excipients include microcrystalline cellulose, corn starch, and magnesium stearate, among others.\u003c\/p\u003e\n\n\u003ch2\u003eContraindications\u003c\/h2\u003e\n\u003cp\u003eTruqap is contraindicated in patients with known hypersensitivity to Capivasertib or to any of the excipients in the formulation. It should not be administered during pregnancy and lactation, unless the potential benefit justifies the risk to the fetus or infant.\u003c\/p\u003e\n\n\u003ch2\u003ePrecautions\u003c\/h2\u003e\n\u003cp\u003eRegular monitoring of patients during treatment with Truqap is essential, as it can cause adverse effects, including but not limited to, alterations in liver and gastrointestinal function. Liver function tests are recommended before starting treatment and at regular intervals during treatment. Patients should be informed about the possibility of adverse reactions and the importance of reporting them immediately to their doctor.\u003c\/p\u003e\n\n\u003ch2\u003eStorage\u003c\/h2\u003e\n\u003cp\u003eTruqap should be stored at room temperature, between 15 and 30 °C, protected from light and humidity. Keep out of reach of children.\u003c\/p\u003e\n\n\u003cp\u003ePrescription required for sale.\u003c\/p\u003e\n\u003cp\u003eConsult your doctor.\u003c\/p\u003e","brand":"Astrazeneca","offers":[{"title":"Default Title","offer_id":46820240621793,"sku":"5000456084406","price":161723.08,"currency_code":"MXN","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0722\/1500\/3361\/files\/WeCare-Pharma-Producto_2e11c68a-f3be-4676-a947-585d52e22735.jpg?v=1756593705","url":"https:\/\/wecarepharma.mx\/en\/products\/truqap-capivasertib-tab-200mg-c64","provider":"WeCare Pharma","version":"1.0","type":"link"}